Ginkgo biloba leaves have the effects of promoting blood circulation, removing blood stasis and dredging collaterals. The 16 batches of Ginkgo biloba leaves produced and sold by Haikou Qi Li Pharmaceutical Co., Ltd. were tested by Jilin and other provincial drug inspection institutions, and 8 batches of Ginkgo biloba leaves did not meet the requirements and were classified as counterfeit drugs; Free quercetin, kaempferol and isorhamnetin in 8 batches of Ginkgo biloba leaves did not meet the requirements and were classified as inferior drugs.
Haikou Qi Li Pharmaceutical Co., Ltd. is suspected of producing and selling counterfeit drugs. The US Food and Drug Administration in Hainan has transferred the case to the public security organs for investigation and handling, and imposed administrative penalties on them, including confiscation of illegally produced products, illegal income and fines, with a total fine of 1087008.4 yuan.
The 1 batch of Ginkgo biloba dispersible tablets produced and sold by Hainan Lihai Pharmaceutical Co., Ltd. was tested by Chongqing Food and Drug Inspection Institute, and the test items of free quercetin, kaempferol and isorhamnetin did not meet the requirements, belonging to inferior drugs. The US Food and Drug Administration in Hainan imposed administrative penalties on the enterprise, including confiscation of illegally produced products, illegal income and fines, with a total fine of 636,435.36 yuan.